Encoded Therapeutics is creating one-time, disease-modifying gene therapies for pediatric central nervous system (CNS) disorders with its cell-selective targeting and regulation platform. The Encoded approach offers potentially unprecedented gene specificity and cell selectivity to unlock novel opportunities by targeting a range of disease mechanisms. Encoded’s technology is compatible with any delivery system to control where and when therapeutic transgenes are expressed, thereby shaping the functionality of target cells and holding broader therapeutic potential beyond CNS disorders. For more information, please visit www.encoded.com, and follow us on LinkedIn, Twitter @EncodedTx and YouTube. Social media guidelines: https://encoded.com/social-media-community-guidelines/
View Top Employees from Encoded Therapeutics Inc.Website | http://www.encoded.com |
Revenue | $19 million |
Employees | 197 (197 on RocketReach) |
Founded | 2014 |
Address | 341 Oyster Point Blvd, South San Francisco, California 94080, US |
Phone | (650) 491-0272 |
Technologies |
JavaScript,
HTML,
PHP
+33 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Business Services General, Drug Discovery, Business Services, Science and Engineering, Therapeutics, Genetics, Healthcare, Health Care |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 541711 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular Encoded Therapeutics Inc. employee's phone or email?
The Encoded Therapeutics Inc. annual revenue was $19 million in 2024.
Stephanie Tagliatela is the Co-Founder and Chief Scientific Officer of Encoded Therapeutics Inc..
197 people are employed at Encoded Therapeutics Inc..
Encoded Therapeutics Inc. is based in South San Francisco, California.
The NAICS codes for Encoded Therapeutics Inc. are [541711, 541, 54171, 54, 5417].
The SIC codes for Encoded Therapeutics Inc. are [28, 283].